September 19, 2019 / 11:21 AM / a month ago

BRIEF-Novartis Pharmaceuticals Canada Says Quebec To Reimburse KISQALI For Eligible Patients In Combination With Letrozole For Treating Metastatic Breast Cancer

Sept 19 (Reuters) - Novartis Pharmaceuticals Canada Inc:

* NOVARTIS PHARMACEUTICALS CANADA - QUEBEC TO REIMBURSE KISQALI FOR ELIGIBLE PATIENTS IN COMBINATION WITH LETROZOLE FOR TREATING METASTATIC BREAST CANCER Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below